• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Granuloma (1876)
Event Date 05/01/2023
Event Type  Injury  
Event Description
Boston scientific corporation became aware of multiple events through the article "lifting agent granuloma presenting as a colonic mass mimicking cancer: a report of three cases" written by nicole l.Mendelson, et al.According to the literature, three cases (a 58-year-old woman captured by mfr report# 3005099803-2023-03216, a 61-yeal-old man captured by mfr report# 3005099803-2023-03233, and a 65-year-old man captured by this report) were identified based on the histological presence of a lifting agent granuloma in a colonic/colorectal resection specimen with associated clinical, imaging and gross concern for invasive malignancy.All three cases resulted in clinical and surgical intervention due to the suspicion of an unresectable lesion that was at least partially involved by a granulomatous reaction due to the use of orise gel lifting agent.This report captures the event of a 65-year-old man who underwent a colonoscopy procedure which presented a 25 mm polyp in the ascending colon.An endoscopic mucosal resection (emr) procedure was performed; however, the procedure was cancelled due to patient discomfort.Two months later, another colonoscopy was performed in which orise gel was used in an attempt to lift the polyp.This was unsuccessful due to underlying scarring and the polyp was removed by way of a cold snare and cold biopsy forceps instead.Three months later, the patient underwent another follow-up colonoscopy, which noted an unresectable polyp at the prior polypectomy site.Due to the unresectable polyp, a laparoscopic hand-assisted right hemicolectomy procedure was performed, and the patient was scheduled to return in three years for a follow-up colonoscopy.Pathological and histological evaluations noted an ill-defined tan mass within the ascending colon and a mass-forming lifting agent granuloma underlying colonic mucosa.No residual adenoma or malignancy was present.
 
Manufacturer Narrative
Block b3: the exact date of the event is unknown.The provided event date was chosen as a best estimate based on the date that the manufacturer became aware of the event.Block d4 and h4: the complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block g2: report source: literature.Dr.Amer k.Abu alfa is the corresponding author.Journal article: mendelson nl, elliott kr, evans ke, frisch nk, abu alfa ak.Lifting agent granuloma presenting as a colonic mass mimicking cancer: a report of three cases.Ame case rep 2023;7:6.Doi: 10.21037/acr-22-59.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORISE GEL
Type of Device
SUBMUCOSAL INJECTION AGENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC LIMITED
model farm road
cork
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key17148591
MDR Text Key317450338
Report Number3005099803-2023-03232
Device Sequence Number1
Product Code PLL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date 06/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/25/2023
Initial Date FDA Received06/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Removal/Correction Number92970101-FA
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
Patient SexMale
-
-